Forward Genetics Finds Fam
Newly Identified Oncogene Can Substitute for EGFR Activation
By Anette Breindl
Wednesday, August 22, 2012
By using a forward genetics approach, two separate teams of researchers have identified related genes as potential oncogenes and mediators of receptor tyrosine kinase inhibitors. Their findings were published back-to-back in the Aug. 13, 2012, online issue of the Journal of Clinical Investigation.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.